Literature DB >> 10946832

Effects of treatment with amphetamine and diazepam on Mycobacterium bovis-induced infection in hamsters.

M Domingues-Junior1, S R Pinheiro, J L Guerra, J Palermo-Neto.   

Abstract

Tuberculosis is an example of an infection with an intracellular bacterium in which sensitivity is determined mainly by the host response. Macrophages are the architectural and functional units of the granulomas described in tuberculosis. Treatment with amphetamine (AMPH) and diazepam has been reported to decrease macrophage activity. The present experiment was undertaken to investigate the effects of AMPH and/or diazepam given alone or in combination on hamster resistance to Mycobacterium bovis. The effects of these treatments on serum cortisol levels were also studied. Adult hamsters were treated i.p. with AMPH (group E1 = 1.0 or 2.0 mg/kg/day), with AMPH (group E2 = 1.0 or 2.0 mg/kg/day) plus diazepam (2.0 mg/kg/day), with diazepam (group E3 = 2.0 mg/kg/day), or with control vehicles (1.0 ml/kg/day) for 40 days. Six days after the beginning of the treatments, the animals received identical inoculum concentrations of M. bovis. Hamsters treated with AMPH plus diazepam exhibited: 1) increased weight loss; 2) increased mortality; 3) increased scores of M. bovis colony forming units (CFU) isolated from liver, lung and spleen; 4) increased granuloma areas measured in the liver, lung and spleen. These effects were not induced by AMPH (1.0 or 2.0 mg/kg/day) given alone and were produced by diazepam (2.0 mg/kg/day) treatment per se. Furthermore, AMPH (2.0 mg/kg/day) and diazepam (2.0 mg/kg/day) given alone or in combination for 20 days increased the serum levels of cortisol in relation to control hamsters, with the effect being higher in the animals treated with both drugs. The present data, which demonstrate an impaired defense against M. bovis in hamsters treated with AMPH plus diazepam or with diazepam alone, were tentatively explained on the basis of a direct and/or indirect action of the drugs on macrophage/lymphocyte activity. In the former case, the effects may be related to stimulation of peripheral benzodiazepine receptor sites (PBR) present on macrophages/lymphocytes and/or to a direct effect of ACTH on immune cells, while in the latter they may be mediated by cortisol via PBR and ACTH stimulation of the adrenals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10946832     DOI: 10.3109/08923970009026012

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  6 in total

1.  Dexmedetomidine-induced neuroprotection: is it translational?

Authors:  Yunzhen Wang; Ruquan Han; Zhiyi Zuo
Journal:  Transl Perioper Pain Med       Date:  2016

2.  Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial.

Authors:  Pratik P Pandharipande; Robert D Sanders; Timothy D Girard; Stuart McGrane; Jennifer L Thompson; Ayumi K Shintani; Daniel L Herr; Mervyn Maze; E Wesley Ely
Journal:  Crit Care       Date:  2010-03-16       Impact factor: 9.097

3.  Recreational drug use and T lymphocyte subpopulations in HIV-uninfected and HIV-infected men.

Authors:  Chun Chao; Lisa P Jacobson; Donald Tashkin; Otoniel Martínez-Maza; Michael D Roth; Joseph B Margolick; Joan S Chmiel; Charles Rinaldo; Zuo-Feng Zhang; Roger Detels
Journal:  Drug Alcohol Depend       Date:  2008-01-03       Impact factor: 4.492

4.  A nationwide cohort study of the association of benzodiazepines with SARS-CoV-2 infection and clinical outcomes.

Authors:  Hye Yoon Park; Junhyun Kwon; Suk Kyoon An; Eun-Cheol Park
Journal:  Sci Rep       Date:  2022-09-24       Impact factor: 4.996

5.  Benzodiazepine augmented γ-amino-butyric acid signaling increases mortality from pneumonia in mice.

Authors:  Robert D Sanders; Alexandra Godlee; Toshifumi Fujimori; John Goulding; Gang Xin; Samira Salek-Ardakani; Robert J Snelgrove; Daqing Ma; Mervyn Maze; Tracy Hussell
Journal:  Crit Care Med       Date:  2013-07       Impact factor: 9.296

6.  In vitro evaluation of the anti-leishmanial activity and toxicity of PK11195.

Authors:  Carlos Eduardo Sampaio Guedes; Beatriz Rocha Simões Dias; Antonio Luis de Oliveira Almeida Petersen; Kercia Pinheiro Cruz; Niara de Jesus Almeida; Daniela Rodrigues Andrade; Juliana Perrone Bezerra de Menezes; Valéria de Matos Borges; Patricia Sampaio Tavares Veras
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-02-05       Impact factor: 2.743

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.